CompletedPhase 4

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

Canada10 participantsStarted 2019-08-06

Plain-language summary

This study aims to develop a standardized universal imaging protocol for ICG-guided fluorescent total thyroidectomy, including quantitative evaluations of the fluorescent signal. Therefore, patients will undergo thyroid surgery (total thyroidectomy) with the use of ICG fluorescence.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients ≥ 18 years
✓. Patients undergoing total thyroidectomy as surgical procedure for thyroid cancer, Graves' disease or goiter
✓. Patients are eligible for surgery
✓. Patients are mentally competent and are able and willing to comply with study procedures
✓. Written informed consent

Exclusion criteria

✕. Patients with a known allergy to ICG or iodinated contrast
✕. Pregnant or lactating women
✕. Patients with previous neck surgery

What they're measuring

Quantification of the fluorescent signal of ICG

Timeframe: At time of surgery

Trial details

NCT IDNCT03969108

SponsorUniversity Health Network, Toronto

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-11-12

View on ClinicalTrials.gov More Thyroid Cancer trials